13th Annual Cancer Symposium Nursing Evaluation Survey

13th Annual Cancer Symposium – Navigating the Cancer Journey for Better Outcomes

November 7, 2019

Maryland Nurses Association Evaluation

*To receive MNA contact hours you must complete the evaluation tool*

	1	2	3	4	5
Examine the scope of systemic therapies available to oncology patients.	Examine the scope of systemic therapies available to oncology patients. 1	Examine the scope of systemic therapies available to oncology patients. 2	Examine the scope of systemic therapies available to oncology patients. 3	Examine the scope of systemic therapies available to oncology patients. 4	Examine the scope of systemic therapies available to oncology patients. 5
Identify the role of next generation sequencing in cancer research and treatment.	Identify the role of next generation sequencing in cancer research and treatment. 1	Identify the role of next generation sequencing in cancer research and treatment. 2	Identify the role of next generation sequencing in cancer research and treatment. 3	Identify the role of next generation sequencing in cancer research and treatment. 4	Identify the role of next generation sequencing in cancer research and treatment. 5
Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship.	Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 1	Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 2	Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 3	Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 4	Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 5
Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up.	Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 1	Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 2	Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 3	Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 4	Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 5
Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment.	Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 1	Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 2	Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 3	Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 4	Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 5
Discuss the why, when, who and how of medical marijuana dispensing in Maryland.	Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 1	Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 2	Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 3	Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 4	Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 5

Examine the scope of systemic therapies available to oncology patients.

Examine the scope of systemic therapies available to oncology patients. 1

Examine the scope of systemic therapies available to oncology patients. 2

Examine the scope of systemic therapies available to oncology patients. 3

Examine the scope of systemic therapies available to oncology patients. 4

Examine the scope of systemic therapies available to oncology patients. 5

Identify the role of next generation sequencing in cancer research and treatment.

Identify the role of next generation sequencing in cancer research and treatment. 1

Identify the role of next generation sequencing in cancer research and treatment. 2

Identify the role of next generation sequencing in cancer research and treatment. 3

Identify the role of next generation sequencing in cancer research and treatment. 4

Identify the role of next generation sequencing in cancer research and treatment. 5

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship.

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 1

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 2

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 3

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 4

Review the differential diagnoses common of behavioral symptoms arising during cancer treatment and survivorship. 5

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up.

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 1

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 2

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 3

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 4

Recognize how evidence based complementary therapies are used during cancer treatment and long term follow-up. 5

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment.

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 1

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 2

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 3

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 4

Explain the role of inflammation and commensal microbial in carcinogenesis and cancer treatment. 5

Discuss the why, when, who and how of medical marijuana dispensing in Maryland.

Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 1

Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 2

Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 3

Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 4

Discuss the why, when, who and how of medical marijuana dispensing in Maryland. 5

	1	2	3	4	5
The content was consistent with the stated program learning outcomes.	The content was consistent with the stated program learning outcomes. 1	The content was consistent with the stated program learning outcomes. 2	The content was consistent with the stated program learning outcomes. 3	The content was consistent with the stated program learning outcomes. 4	The content was consistent with the stated program learning outcomes. 5
Audiovisuals and/or handouts were effective.	Audiovisuals and/or handouts were effective. 1	Audiovisuals and/or handouts were effective. 2	Audiovisuals and/or handouts were effective. 3	Audiovisuals and/or handouts were effective. 4	Audiovisuals and/or handouts were effective. 5
The physical environment was conducive to learning.	The physical environment was conducive to learning. 1	The physical environment was conducive to learning. 2	The physical environment was conducive to learning. 3	The physical environment was conducive to learning. 4	The physical environment was conducive to learning. 5

The content was consistent with the stated program learning outcomes.

The content was consistent with the stated program learning outcomes. 1

The content was consistent with the stated program learning outcomes. 2

The content was consistent with the stated program learning outcomes. 3

The content was consistent with the stated program learning outcomes. 4

The content was consistent with the stated program learning outcomes. 5

Audiovisuals and/or handouts were effective.

Audiovisuals and/or handouts were effective. 1

Audiovisuals and/or handouts were effective. 2

Audiovisuals and/or handouts were effective. 3

Audiovisuals and/or handouts were effective. 4

Audiovisuals and/or handouts were effective. 5

The physical environment was conducive to learning.

The physical environment was conducive to learning. 1

The physical environment was conducive to learning. 2

The physical environment was conducive to learning. 3

The physical environment was conducive to learning. 4

The physical environment was conducive to learning. 5

	1	2	3	4	5
Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology)	Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 1	Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 2	Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 3	Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 4	Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 5
Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing)	Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 1	Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 2	Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 3	Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 4	Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 5
Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment)	Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 1	Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 2	Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 3	Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 4	Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 5
Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies)	Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 1	Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 2	Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 3	Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 4	Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 5
Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy)	Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 1	Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 2	Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 3	Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 4	Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 5
Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know)	Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 1	Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 2	Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 3	Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 4	Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 5

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology)

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 1

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 2

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 3

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 4

Kimberly Schlesinger, MD (The Changing Landscape of Medical Oncology) 5

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing)

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 1

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 2

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 3

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 4

Shruti Murali, MD (An Era of Personalized Medicine Using Next Generation Sequencing) 5

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment)

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 1

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 2

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 3

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 4

Harry Brandt, MD (Psychiatric Considerations in Cancer Treatment) 5

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies)

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 1

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 2

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 3

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 4

Virginia Jump, CRNP (What Are Your Patients Doing ”Out There”? – An Update on Complimentary Therapies) 5

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy)

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 1

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 2

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 3

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 4

Giorgio Trinchieri, MD (The Role of the Commensal Microbiota in Carcinogenesis and Cancer Therapy) 5

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know)

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 1

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 2

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 3

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 4

Katie Arensmeyer, MSN, ANP-BC, AOCNP (Medical Marijuana: What You Need To Know) 5

13th Annual Cancer Symposium Nursing Evaluation

Question Title

* 1. Please fill out your contact information to receive credit.

Question Title

* 2. Please rate the extent to which you are now able to meet each of the learning outcomes. Excellent is 5, Poor is 1.

Question Title

* 3. Additional comments?

Question Title

* 4. Please rate the extent to which you were satisfied with these aspects of the conference. Excellent is 5, Poor is 1.

Question Title

* 5. Additional comments?

Question Title

* 6. Do you plan to make a change in your nursing practice as a result of attending this educational activity? If yes, please describe.

Question Title

* 7. Please rate the presenting faculty. Excellent is 5, Poor is 1.

Question Title

* 8. Additional comments?

Question Title

* 9. Suggested topics for the 2020 Cancer Symposium.